Search research articles
Contact Us
Filters
Showing results (41-50 of 57) with videos related to
Page
of 6
Sort By:
The Journal of Clinical Investigation
|
May 24, 2008
CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors
Sergey V Shmelkov, Jason M Butler, Andrea T Hooper, et al.
Acta Haematologica
|
September 16, 2016
Telomere Length Recovery: A Strong Predictor of Overall Survival in Acute Promyelocytic Leukemia
Muhamed Baljevic, Bogdan Dumitriu, Ju-Whei Lee, et al.
Blood Advances
|
April 12, 2024
Clonal hematopoiesis and inflammation in the vasculature: CHIVE, a prospective, longitudinal clonal hematopoiesis cohort and biorepository
Morgan L Shannon, J Brett Heimlich, Sydney Olson, et al.
Ejhaem
|
July 18, 2022
Selinexor, daratumumab, and dexamethasone in patients with relapsed or refractory multiple myeloma
Cristina Gasparetto, Suzanne Lentzsch, Gary Schiller, et al.
British Journal of Haematology
|
September 16, 2022
Daratumumab plus lenalidomide, bortezomib and dexamethasone in newly diagnosed multiple myeloma: Analysis of vascular thrombotic events in the GRIFFIN study
Douglas W Sborov, Muhamed Baljevic, Brandi Reeves, et al.
Cancer Cell
|
April 16, 2015
Mutational cooperativity linked to combinatorial epigenetic gain of function in acute myeloid leukemia
Alan H Shih, Yanwen Jiang, Cem Meydan, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 1, 2023
Selinexor-Based Triplet Regimens in Patients With Multiple Myeloma Previously Treated With Anti-CD38 Monoclonal Antibodies
Gary J Schiller, Brea C Lipe, Nizar J Bahlis, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 18, 2023
Systemic Light Chain Amyloidosis, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology
Shaji K Kumar, Natalie S Callander, Kehinde Adekola, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 7, 2020
Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology
Shaji K Kumar, Natalie S Callander, Kehinde Adekola, et al.
Ejhaem
|
December 5, 2022
Selinexor-based regimens in patients with multiple myeloma after prior anti-B-cell maturation antigen treatment
Muhamed Baljevic, Cristina Gasparetto, Gary J Schiller, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 57) with videos related to
Sort By:
Page
of 6
The Journal of Clinical Investigation
|
May 24, 2008
CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors
Sergey V Shmelkov, Jason M Butler, Andrea T Hooper, et al.
Acta Haematologica
|
September 16, 2016
Telomere Length Recovery: A Strong Predictor of Overall Survival in Acute Promyelocytic Leukemia
Muhamed Baljevic, Bogdan Dumitriu, Ju-Whei Lee, et al.
Blood Advances
|
April 12, 2024
Clonal hematopoiesis and inflammation in the vasculature: CHIVE, a prospective, longitudinal clonal hematopoiesis cohort and biorepository
Morgan L Shannon, J Brett Heimlich, Sydney Olson, et al.
Ejhaem
|
July 18, 2022
Selinexor, daratumumab, and dexamethasone in patients with relapsed or refractory multiple myeloma
Cristina Gasparetto, Suzanne Lentzsch, Gary Schiller, et al.
British Journal of Haematology
|
September 16, 2022
Daratumumab plus lenalidomide, bortezomib and dexamethasone in newly diagnosed multiple myeloma: Analysis of vascular thrombotic events in the GRIFFIN study
Douglas W Sborov, Muhamed Baljevic, Brandi Reeves, et al.
Cancer Cell
|
April 16, 2015
Mutational cooperativity linked to combinatorial epigenetic gain of function in acute myeloid leukemia
Alan H Shih, Yanwen Jiang, Cem Meydan, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 1, 2023
Selinexor-Based Triplet Regimens in Patients With Multiple Myeloma Previously Treated With Anti-CD38 Monoclonal Antibodies
Gary J Schiller, Brea C Lipe, Nizar J Bahlis, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 18, 2023
Systemic Light Chain Amyloidosis, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology
Shaji K Kumar, Natalie S Callander, Kehinde Adekola, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 7, 2020
Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology
Shaji K Kumar, Natalie S Callander, Kehinde Adekola, et al.
Ejhaem
|
December 5, 2022
Selinexor-based regimens in patients with multiple myeloma after prior anti-B-cell maturation antigen treatment
Muhamed Baljevic, Cristina Gasparetto, Gary J Schiller, et al.
Page
of 6